Erythropoietin and Diabetic Retinopathy

被引：2

作者：

Semeraro, Francesco ^{[1
]}

Cancarini, Anna ^{[1
]}

Forbice, Eliana ^{[1
]}

Morescalchi, Francesco ^{[1
]}

Donati, Simone ^{[2
]}

Azzolini, Claudio ^{[2
]}

Costagliola, Ciro ^{[3
]}

机构：

[1] Univ Brescia, Dept Med Surg Specialties Radiol Sci & Publ Hlth, P leSpedaliCivili 1, I-25123 Brescia, Italy

[2] Univ Insubria, Sch Med, Dept Surg & Morphol Sci, Ophthalmol Sect, Varese, Italy

[3] Univ Molise, Dept Med & Hlth Sci, Campobasso, Italy

来源：

JOURNAL OF DIABETES & METABOLISM | 2013年 / 4卷 / 06期

关键词：

Erythropoietin; Diabetic retinopathy; Retina angiogenesis; Neuroprotection;

D O I：

10.4172/2155-6156.1000283

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Diabetic retinopathy (DR) is the main cause of visual impairment in industrialized countries. Great efforts are in place to search for new therapies able to prevent the development of DR and the onset of its complications. At present, therapy consists of anti-VEGF intra vitreal injections and is aimed at preventing the main causes of visual impairment, that is, macular oedema and retinal proliferation. However, the current knowledge has led us to hypothesize about the roles of other factors implicated in the pathogenesis of macular oedema and retinal proliferation; erythropoietin (EPO) is one such compound.

引用

页数：7

共 50 条

[21] NEUROPROTECTIVE EFFICACY OF ARA290, AN ERYTHROPOIETIN DERIVED PEPTIDE, IN DIABETIC RETINOPATHY
Canning, P.
O'Leary, O.
Allen, L. D.
Brines, M.
Cerami, A.
Stitt, A. W.
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2017, 27 (03) : E113 - E113
[22] Erythropoietin and retinopathy of prematurity
Romagnoli, C.
Tesfagabir, M. G.
Giannantonio, C.
Papacci, P.
EARLY HUMAN DEVELOPMENT, 2011, 87 : S39 - S42
[23] Erythropoietin therapy for early diabetic retinopathy through its protective effects on retinal pericytes
Wang, Zhao-Yang
Zhao, Ke-Ke
Zhao, Pei-Quan
MEDICAL HYPOTHESES, 2011, 76 (02) : 266 - 268
[24] Gene-gene interaction of erythropoietin gene polymorphisms and diabetic retinopathy in Chinese Han
Fan, YanFei
Fu, Yin-Yu
Chen, Zhi
Hu, Yuan-Yuan
Shen, Jie
EXPERIMENTAL BIOLOGY AND MEDICINE, 2016, 241 (14) : 1524 - 1530
[25] Evaluation of erythropoietin efficacy on diabetic retinopathy based on molecular hyperspectral imaging (MHSI) system
Liu Hong-Ying
Li Qing-Li
Xu Liang
Wang Yi-Ting
Liu Jin-Gao
Xue Yong-Qi
JOURNAL OF INFRARED AND MILLIMETER WAVES, 2012, 31 (03) : 248 - 253
[26] A hypothesis: Can erythropoietin administration affect the severity of retinopathy in diabetic patients with renal failure?
Diskin, Charles J.
Stokes, Thomas J.
Dansby, Linda M.
Radcliff, Lautrec
Carter, Thomas B.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2007, 334 (04): : 260 - 264
[27] Erythropoietin and retinopathy: the beginning of an understanding
Diskin, C. J.
BRITISH JOURNAL OF OPHTHALMOLOGY, 2008, 92 (04) : 574 - 574
[28] Association Between Erythropoietin Gene Polymorphisms and Diabetic Retinopathy (vol 128, pg 102, 2010)
Abhary
ARCHIVES OF OPHTHALMOLOGY, 2010, 128 (03) : 311 - 311
[29] Expression of the erythropoietin receptor in patients with proliferative diabetic retinopathy and its correlation with postoperative visual prognosis
He, Guiqin
Zhou, Junhong
Yang, Xiaoli
ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (06) : 4010 - 4016
[30] Diabetic retinopathy
Evans, SA
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1996, 89 (04) : P230 - P231

← 1 2 3 4 5 →